Alkemy S.p.A.

As of March 31, 2025, Alkemy S.p.A. has 5.79M shares outstanding.

As of March 31, 2025, Alkemy S.p.A. trades at a trailing price-to-earnings ratio of 14.20. The price-to-sales ratio is 0.61, and the price-to-book ratio stands at -369.09.

These figures are as of March 31, 2025. The EV/Sales ratio of 0.56 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Alkemy S.p.A. trades at an EV/FCF ratio of 6.02, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of March 31, 2025, Alkemy S.p.A. maintains a current ratio of 1.16, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 15.29, indicating elevated leverage, while an interest coverage ratio of -0.64 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2025, Alkemy S.p.A. posted a negative return on equity (ROE) of -178.88, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -13.59, reflecting losses generated across the asset base.

As of the close on July 11, 2025, Alkemy S.p.A.'s stock has declined approximately 0.41% over the past 52 weeks. The 50-day moving average sits at 11.93, while the 200-day moving average is 11.76.

Over the twelve months ended March 31, 2025, Alkemy S.p.A. posted a gross margin of 61.43, reflecting its pricing power and cost economics. The operating margin of -0.97 and net profit margin of -13.99 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2025. Free cash flow yield stands at 13.02, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 7.86, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Alkemy S.p.A. shareholders.

As of March 31, 2025, Alkemy S.p.A. has an Altman Z-Score of 2.42, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.